Open Access 01-12-2010 | Poster presentation
HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
Published in: Journal of the International AIDS Society | Special Issue 4/2010
Login to get access